FdaApplication
BLA 761350
Identifiers
- fda_app_no: BLA761350
Properties
| Property | Value |
|---|---|
| applicant_name | Samsung Bioepis Co., Ltd. |
| application_type | BLA |
| approval_date | 2024-05-20 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OPUVIZ | AFLIBERCEPT-YSZY | 2MG/0.05ML | Injection |
1 product